ArticleCancers2024

Profiling the Cardiovascular Toxicities of CDK4/6 Inhibitors: A Real-World Pharmacovigilance Study.

Jae Hyun KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.